Laskow-Pooley David 4
4 · Marker Therapeutics, Inc. · Filed Jun 10, 2021
Insider Transaction Report
Form 4
Laskow-Pooley David
Director
Transactions
- Award
Common Stock
2021-06-08+12,658→ 55,223 total
Footnotes (1)
- [F1]Represents the portion of the annual board retainer for each non-employee director payable in immediately vested common stock under the Company's 2020 Equity Incentive Plan and based on the closing price of $3.16 per share, on the day immediately preceding the date of the Company's 2021 annual meeting.